Novo Integrated Sciences Corp (NVOS): Price to Sales

Corporate company logo of Novo Integrated Sciences Corp (NVOS)

How can medical sustainability be improved through data digitalization? P/S multiple fluctuations on this GURU.Markets chart for Novo Integrated Sciences (NVOS) show that the parameter reaches 0.20. However, the trend is complicated by a working capital deficit and risky acquisitions. The situation is further exacerbated by a lack of operating profit and the marginalization of the business against tech giants, which calls into question the effectiveness of current investment attraction methods.

NVOS: Novo Integrated Sciences, Inc. P/S Multiple 07/04/2022 - 11/16/2024

Novo Integrated (NVOS) - metric breakdowns and financial figures

- current price and projected stock value:
Price Chart Novo Integrated Sciences Inc|NVOS - Price Target Chart
- stock exchange capitalization data:
Market Value Novo Integrated Sciences, Inc.|NVOS - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Accounting Value of a Share Novo Integrated Sciences|NVOS - Book Capitalization|Market Capitalization to Book Value novointegrated.com|NVOS - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Equity Ratio Novo Integrated Sciences|NVOS - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Novo Integrated Sciences|NVOS - Company Aggregate Debts|Debts to Book Value Novo Integrated Sciences Corp|NVOS - Company Long-Term Debts|Short-Term Indebtedness Novo Integrated Sciences|Intermediate Coverage Ratio novointegrated.com
- earnings and valuation multiples information:
NVOS - Net Profit|Projected Future Earnings Novo Integrated Sciences|NVOS - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Novo Integrated|NVOS - PEG Multiple|Company Value to EBITDA Novo Integrated Sciences Corp|NVOS - Operating profit EBITDA|Earnings per share for the last 12 months Novo Integrated Sciences|NVOS - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months novointegrated.com|NVOS - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Novo Integrated Sciences
- issuer revenue and sales details:
NVOS - Revenue and Sales Volume|Company Future Sales Volume Novo Integrated Sciences, Inc.|NVOS - P/S Multiple|Market Cap to Expected Sales Ratio Novo Integrated Sciences Corp|NVOS - Sales Growth YoY (TTM)
General company analysis:NVOS - Novo Integrated Sciences, Inc.
Manufactured products of Novo Integrated Sciences Inc

The complexity of integrating medical and IT services at Novo Integrated Sciences (NVOS) amid a capital shortage increases risks during aggressive expansion. The ratio of market capitalization to annual revenue allows for an assessment of the premium paid for this growth; therefore, analyzing P/S levels on this chart helps investors timely recognize signs of an overbought asset or a signal of business stagnation.

Competing companies

HCA (HCA Healthcare) - Market Capitalization-to-Revenue Ratio|Tenet Healthcare Corporation - Market Cap to Revenue|Fresenius Medical (FMS) - Price to Sales|Solventum Corp - P/S Multiple|Price-to-Sales Ratio EHC|Universal Health Services (UHS) - Price-to-Revenue Ratio|DaVita - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue RDNT|OPCH: Market Capitalization-to-Revenue Ratio|Market Cap to Revenue SGRY (Surgery Partners, Inc.)|PINC (Premier, Inc.) - Market Capitalization-to-Revenue Ratio|National Vision - Market Cap to Revenue|Price-to-Revenue Coefficient Progyny Inc (PGNY)|Ardent Health - P/S Multiple|Price-to-Revenue Coefficient Select Medical Corp SEM|ASTH: P/S Multiple|Market Cap to Revenue Ratio MD|USPH (US Physical Therapy Inc) - P/S Multiple|PNTG: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Organogenesis Corp (ORGO)|NUTX (Nutex Health Corp) - Market Capitalization-to-Revenue Ratio|P/S Multiple AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Price to Sales|EOLS - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Market Cap to Revenue|Market Cap to Revenue Ratio MDWD|Price-to-Revenue Ratio biote Corp.|Price to Sales thejoint.com JYNT|P/S Multiple DCGO|Market Cap to Revenue P3 Health PIII|P/S Multiple GANX (Gain Therapeutics Inc.)|P/S Multiple EUDA Health Holdings Limited EUDA|baselmedical.com - P/S Multiple|CLGN: Price-to-Revenue Ratio|Cuprina Holdings (Cayman) Ltd. (CUPR) - Price-to-Revenue Ratio|Market Cap to Revenue Concord Medical|AMS (American Shared Hospital Services Inc) - P/S Multiple|MEDIROM Corp (MRM) - Price-to-Revenue Coefficient|P/S Multiple ALBT|Price-to-Revenue Coefficient DIH Holding|P/S Multiple XAGE (carmellcosmetics.com)|NIVF: Market Cap to Revenue Ratio|ATIP: Market Cap to Revenue|CareMax Medical Group - Market Cap to Sales Volume|Kindly MD (KDLY) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio MODV|SSY (SunLink Health Systems Inc.) - P/S Multiple|BACK (IMAC Holdings Inc) - Market Cap to Sales Volume